Federal health programs secure supply of advanced brain and cancer scans
What happened
A federal contract ensures the continued supply of specialized diagnostic agents used in brain and cancer scans. This means patients in government health programs will maintain access to advanced imaging for conditions like Alzheimer's disease.
Why it matters
These agents, Amyvid and FDG, are critical for diagnosing conditions like Alzheimer's disease and various cancers using PET scans. This contract ensures that federal health programs can continue to offer these advanced diagnostic tools to their patients without interruption.
The signal
The question is whether the cost of these specialized agents changes significantly in future contract renewals.